Top 10 Key Players in the Vietnam Scleroderma Market | Insights & Top Companies 2026

Top 10 Key Players in the Vietnam Scleroderma Market

The Vietnam Scleroderma Market is driven by leading companies, each holding a significant market share through advanced therapeutic drugs and clinical research for systemic sclerosis management. Key players in the market include Boehringer Ingelheim Vietnam, Roche Vietnam, and Stellapharm J.V. Co., Ltd.

Vietnam Scleroderma Market Overview

According to 6Wresearch, the Vietnam scleroderma market is rising due to the increased occurrence of autoimmune disorders and the growing adoption of biological therapies. Scleroderma is an autoimmune condition, recognized by the hardening of the skin and potential damage to internal organs such as the lungs and heart.

The growth of the market is being contributed through increased use of specialized antifibrotic therapies and hospital-based multidisciplinary care. The healthcare infrastructure is becoming more specialized, with an increasing number of rheumatology departments in major and specialized rare disease centres contributing to the expansion of the pharmaceutical supply chain.

Competitive Landscape

The competitive landscape of the Vietnam Scleroderma Industry includes global pharmaceutical giants and innovative domestic firms, offering the latest technology-based therapeutic tools required for the management of the disease. The market leaders are actively engaged in the development and supply of immunosuppressants, antifibrotics, and vasodilators.

Below is a list of leading players operating in the Vietnam Scleroderma Market:

1. Boehringer Ingelheim (Vietnam) Co., Ltd.

Boehringer Ingelheim is a global leader in respiratory and autoimmune health, providing nintedanib, the primary treatment for scleroderma.

2. Roche Vietnam Co., Ltd.

Roche is a dominant force, with its biological therapies used to slow the rate of lung function decline in systemic sclerosis.

3. Stellapharm J.V. Co., Ltd.

Stellapharm is a leading domestic brand offering high-quality, affordable supportive medications and immunosuppressants.

4. Novartis Vietnam Co., Ltd.

Novartis provides essential rheumatological treatments and is actively involved in clinical trials for next-generation autoimmune therapies.

5. Pfizer (Vietnam) Limited

Pfizer maintains a strong presence in the central nervous and inflammatory system market, providing corticosteroids for scleroderma symptom management.

6. Zuellig Pharma Vietnam

Zuellig Pharma ensures the supply chain integrity of specialized rare disease medications.

7. Sanofi Vietnam

Sanofi focuses on specialized therapies for rare diseases and chronic inflammatory conditions, contributing to the broader autoimmune treatment landscape.

8. GSK Vietnam (GlaxoSmithKline)

GSK is a key player in immunology, offering medications that manage the inflammatory components of systemic sclerosis.

9. AstraZeneca Vietnam Co., Ltd.

AstraZeneca provides cardiovascular and respiratory medications that are critical for managing scleroderma complications.

10. Takeda Vietnam

Takeda is a specialized player in rare diseases and inflammation, providing advanced treatments for complex autoimmune conditions.

Top 10 Key Players in the Vietnam Scleroderma Market: FAQs